CSF2 and melanoma: The exception is a CRAd encoding a combination of MART1 melanoma antigen, granulocyte-macrophage colony-stimulating factor (GM-CSF) cytokine, and an shRNA silencing transforming growth factor β2 (TGF-β2) [96].